Clinical Trials Browser

Completed × Celecoxib × Clear all

NCT01150045 2026-05-19

Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery

Phase 3 Completed

2,527 enrolled 14 charts

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT02115074 2026-03-18

FLUVABREX

Phase 1 Completed

Glioma, Recurrence

NCT01881048 2026-01-29

Window of Opportunity Study Targeting the Inflammatory Milieu

Phase EARLY_PHASE1 Completed

Breast Neoplasms

NCT02885974 2025-07-28

BLAST

Phase 1 Completed

Urinary Bladder Neoplasms

NCT02030964 2025-02-17

DFMO

Phase 1 Completed

Neuroblastoma

NCT03084536 2024-12-24

PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery

Phase 2 Completed

134 enrolled 9 charts

Breast Neoplasms

NCT02641314 2024-05-10

METRO-NB2012

Phase 2 Completed

Neuroblastoma

NCT03728179 2024-02-20

RACIN

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT04081389 2023-09-11

Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer

Phase 1 Completed

9 enrolled 17 charts

Breast Carcinoma In Situ, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00846430 2023-08-30

Medical Treatment of "High-Risk" Neurofibromas

Phase 2 Completed

9 enrolled 9 charts

Neurofibroma, Neurofibromatosis 1

NCT03599453 2023-07-18

Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer

Phase EARLY_PHASE1 Completed

Triple Negative Breast Neoplasms

NCT00538031 2023-04-21

Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Phase 2 Completed

52 enrolled 10 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT01285817 2023-03-13

SFCE METRO 01

Phase 2 Completed

Survival Without Progression

NCT00503035 2023-02-13

Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers

Phase 2 Completed

51 enrolled 10 charts

Gastrointestinal

Adenomatous Polyposis Coli, Colorectal Neoplasms

NCT05438303 2023-01-12

Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female Volunteers

Phase 1 Completed

Breast Neoplasms

NCT03403634 2022-03-02

Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver

Phase 2 Completed

19 enrolled 15 charts

Gastrointestinal

Colorectal Neoplasms

NCT02484664 2022-01-20

COLA

Phase 2 Completed

12 enrolled 11 charts

Lymphangioleiomyomatosis

NCT00112502 2021-10-18

Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme

Phase 2 Completed

178 enrolled 23 charts

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT02770378 2021-10-05

A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma

Phase 1/2 Completed

Glioblastoma

NCT00033371 2020-09-29

Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis

Phase 2 Completed

205 enrolled 16 charts

Gastrointestinal

Adenomatous Polyposis Coli, Colorectal Neoplasms

NCT00020878 2020-08-03

Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00062179 2020-08-03

Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02151448 2020-07-20

αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies

Phase 1/2 Completed

64 enrolled 18 charts

Peritoneal Neoplasms

NCT02429427 2020-06-23

REACT

Phase 3 Completed

2,639 enrolled 12 charts

Breast Neoplasms

NCT02280694 2020-02-12

LDMchemoCRC

Phase 2 Completed

Gastrointestinal

Colorectal Neoplasms

NCT02108366 2019-10-21

Treatment of Severe Influenza A Infection

Phase 3 Completed

Influenza, Human, Lymphoma, Follicular

NCT00037817 2019-09-30

Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies

Phase 1 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

NCT02961998 2019-09-10

Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail

Phase 4 Completed

Gastrointestinal

Carcinoma, Hepatocellular

NCT03059238 2019-08-13

Parecoxib Versus Celecoxib Versus Oxycodone in Pain Control for Transcatheter Chemoembolization Procedure

Phase 3 Completed

Gastrointestinal

Agnosia, Liver Neoplasms, Pain, Postoperative

NCT00061893 2019-02-15

Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors

Phase 2 Completed

38 enrolled 10 charts

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT00022399 2019-02-08

Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT00685568 2018-11-07

Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis

Phase 1 Completed

GastrointestinalOther neoplasm

Colonic Neoplasms, Adenomatous Polyposis Coli, Precancerous Conditions, Rectal Neoplasms, Colorectal Neoplasms

NCT00068432 2018-10-31

Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT01220973 2018-06-08

Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer

Phase 2 Completed

27 enrolled 6 charts

Prostatic Neoplasms

NCT00290680 2018-04-10

Bortezomib and Celecoxib in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00052611 2018-03-29

Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia

Phase 2 Completed

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Salivary Gland Neoplasms

NCT00400374 2018-03-15

Secondary Primary Tumor Prevention With EGFR, OSI-774, and Cyclooxygenase-2

Phase 1 Completed

Head and Neck Neoplasms

NCT01695226 2018-01-09

Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT00137852 2017-09-20

Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer

Phase 2 Completed

Gastrointestinal

Esophageal Neoplasms

NCT00081263 2017-09-15

Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia

Phase 2 Completed

130 enrolled 9 charts

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT01425476 2017-08-09

Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors

Phase 1/2 Completed

Breast Neoplasms

NCT01769625 2017-08-09

Changes in Biomarkers Using Prostaglandin Inhibitors

Phase 1/2 Completed

Biomarker Change Linked to Breast Cancer

NCT00047281 2017-07-11

Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma

Phase 2 Completed

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00047294 2017-07-11

Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Phase 2 Completed

Glioblastoma, Glioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00081848 2017-07-02

Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive Solid Tumors

Phase 1 Completed

Gastrointestinal

Colonic Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Neoplasms

NCT00582660 2017-06-15

UAB0040

Phase 2 Completed

40 enrolled 7 charts

Gastrointestinal

Colorectal Neoplasms

NCT00970502 2017-04-10

Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer

Phase 1/2 Completed

15 enrolled 16 charts

Head and Neck Neoplasms, Laryngeal Neoplasms, Paranasal Sinus Neoplasms, Pharyngeal Neoplasms

NCT00499655 2017-03-29

Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer

Phase 2 Completed

107 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT00953849 2017-03-07

Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity

Phase 1/2 Completed

21 enrolled 10 charts

Mouth Neoplasms

NCT02401295 2017-02-23

ATRA, Celecoxib, and Itraconazole as Maintenance

Phase 1 Completed

Multiple Myeloma